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Two recent studies (1,2) from Hans Krayenbuehl's labo-
ratory support the concept that the dynamic nature of a
coronary stenosis may determine hemodynamic and clinical
consequences in patients with classic angina. Specifically.
new data regarding the pathophysiology of exercise-induced
ischemia and the mechanism of the therapeutic benefit of
nitroglycerin and propranolol suggest that the coronary ste-
nosis is an active site that can be affected by both endog-
enous (alpha-receptor stimulation) and exogenous (beta-re-
ceptor blockade) alterations in sympathetic tone,
Gage et at. (I) provided evidence. for the first time, that
exercise in patients with coronary disease predictably causes
vasoconstriction at the site of the stenosis. an effect that is
reversed by sublingual nitroglycerin after exercise and by
pretreatment with 0.1 mg of intracoronary nitroglycerin.
The magnitude of the changes in the luminal area of the
coronary stenosis was significant: exercise caused a decrease
to 71% of the area at rest and sublingual nitroglycerin after
exercise increased the luminal area to 140% of the control
area. Furthermore, when intracoronary nitroglycerin was
given before exercise, the stenotic area increased to 122(';(,
of the control value with exercise. Now. in this issue of the
Journal, Gaglione et at. (2) report that the intracoronary
administration of I mg of propranolol before exercise did
not potentiate coronary vasoconstriction at rest and actually
prevented stenosis constriction during exercise. In addition.
sublingual nitroglycerin after exercise further increased the
coronary stenosis area, thus implying an additive effect.
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Taken together. these studies raise two intriguing ques-
tions: I) Does exercise-induced ischemia occur solely by
increasing myocardial oxygen demand in the setting of a
fixed obstruction limiting blood supply. or is there an ad-
ditional dynamic alteration in stenotic dimension in which
blood flow may actually decrease as a primary mechanism",
and 2) in exercise-induced ischemia, do antianginal medi-
cations act essentially by reducing myocardial oxygen de-
mand. allowing redistribution of flow to ischemic myocar-
dium. or is stenosis dilation an important component of the
antianginal effect?
Role of exercise-induced coronary vasoconstriction.
Several questions arise when evaluating the possible role of
exercise-induced vasoconstriction. The most fundamental
issue is to what degree a coronary stenosis can actually
manifest such a response. In this regard. Brown et at. (3)
pointed out that relatively small changes in luminal diameter
at the site of stenosis (involving smooth muscle contraction
and relaxation in a compliant portion) caused by alterations
in autonomic tone can have major consequences (an inverse
fourth-power effect) on stenosis resistance and coronary
flow.
Initial studies with isometric handgrip exercise and hand
immersion in ice water (cold pressor test) seemed to confirm
the occurrence of constriction at the stenotic site. With
advanced quantitative coronary angiographic techniques, it
was shown that the area of the stenotic lumen decreased by
35% during isometric handgrip, whereas a second handgrip
test during the administration of intracoronary nitroglycerin
resulted in a 32% increase in the stenotic area despite no
difference in rate-pressure product (4,5). In addition, cold
pressor testing (6.7) in patients with coronary disease was
shown to increase coronary resistance, with variable changes
in flow. This effect was ascribed. without reported evidence,
to changes in stenotic diameter.
Subsequent analysis. however, has raised significant
questions about the precise site and nature (~f the vasocon-
striction. Angiographic evidence of minimal. diffuse coro-
nary vasoconstriction suggested that it was probably the
arteriolar bed distal to the stenotic site that was vasocon-
stricting, not the stenosis itself in most instances (8,9).
Because the small coronary arterioles distal to a hemody-
namically significant stenosis represent a potentially signif-
icant component of resistance to flow (10, II) and are ca-
pable of responding to changes in autonomic tone, it may
not be necessary to invoke a dynamic change in stenotic
area (8). There are also data to support several mechanisms
by which a compliant stenosis may undergo dimensional
change passively. The calculated stenosis resistance is de-
pendent on perfusion pressure and on distal coronary pres-
sure and resistance (11-17). Interventions that decrease
coronary pressure distal to a stenosis increase the hemo-
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dynamic resistance of the stenosis, whereas raising distal
pressure can decrease this resistance (13,14). When vaso-
active agents are administered in the presence of a partial
arterial constriction, the normal coronary flow response can
be attenuated or even reversed (15). In addition, it is possible
for a decrease in perfusion pressure to allow some "col-
lapse" of the stenotic segment, with a consequent increase
in stenosis resistance (14,15). Thus, the combination of
several mechanisms probably contribute to acute alterations
in stenosis geometry with resultant changes in stenosis re-
sistance (17).
The studies by Gage et al. (I) and Gaglione et al. (2) do
not shed additional light on these issues because they did
not assess changes in coronary flow and distal coronary
pressure. Such data would be necessary to determine whether
the observed effects on stenotic dimension are primary or
secondary to changes in pressure on either side of the ste-
nosis, because several previous studies (5,18) have docu-
mented discrepancies between changes in coronary blood
flow and vessel dimension.
Mechanisms of antianginal drug effect: therapeutic
implications. With the demonstration that nitroglycerin and
nitroprusside have significant coronary vasodilatory effects
on the coronary stenosis (19,20), the possible therapeutic
implications became apparent. How important is this va-
sodilatory effect in a patient with exertional angina? Many
clinical and experimental studies suggest that the primary
effect of antianginal medications is to reduce the determi-
nants of myocardial oxygen demand, and it remains con-
troversial whether nitroglycerin dilates the coronary stenosis
or the normal lumen (21,22). Studies of the therapeutic
action of nitroglycerin (23-25), propranolol (26,27) and
nifedipine (23,28) have shown that coronary and myocardial
flow usually decrease. However, because demand decreases
more than supply, blood flow is favorably redistributed to
the ischemic myocardium, especially the subendocardium
(24,29,30).
This traditional view of the action of antianginal agents
provides a perfectly acceptable explanation for their ther-
apeutic benefit in patients whose exertional angina is in-
duced by exceeding a critical rate-pressure product, thus
suggesting a fixed obstruction. On the other hand, coronary
stenosis dilation may better explain the beneficial effect in
patients with rest angina (31), in those with documented
spasm (32) and in the setting of exercise-related stenosis
vasoconstriction (33,34). Finally, there may be intermediate
forms ("mixed angina"), in which a variable combination
of both mechanisms of angina occur. Patients with mixed
angina may have diurnal variations in their anginal patterns
in which it can be demonstrated that varying amounts of
exertion can provoke angina. In this group of patients, an-
tianginal agents may be effective through both stenosis di-
lation and reduced demand, either simultaneously or in al-
ternating ways depending on the operative mechanism of
angina induction. The possibility that beta-receptor blockers
may induce coronary vasoconstriction has led some clini-
cians (35) to consider them contraindicated in patients with
those manifestations suggesting increases in coronary va-
somotor tone.
It is in this context that the importance of the report by
Gaglione et al. (2) is to be appreciated. By administering a
low dose of intracoronary propranolol, the inherent rate-
pressure product was not altered and only "local" beta-
adrenergic blocking properties were affected. No change in
vessel dimension occurred at rest, and the predicted exer-
cise-induced decrease in stenotic diameter was prevented.
Without knowing the coronary flow response, one is unable
to go beyond these provocative observations. Further studies
are therefore necessary to answer the question: In what
clinical situations are changes in coronary stenoses due to
an active process, and when are such changes a passive
response?
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